Fusion Pharmaceuticals Buy Hold or Sell Recommendation
| FUSNDelisted Stock | USD 3.75 0.33 8.09% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Fusion Pharmaceuticals is 'Not Rated'. The recommendation algorithm takes into account all of Fusion Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. In addition, we conduct extensive research on individual companies such as Fusion and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Fusion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Fusion |
Execute Fusion Pharmaceuticals Buy or Sell Advice
The Fusion recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Fusion Pharmaceuticals. Macroaxis does not own or have any residual interests in Fusion Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Fusion Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Fusion Pharmaceuticals Trading Alerts and Improvement Suggestions
| Fusion Pharmaceuticals is not yet fully synchronised with the market data | |
| Fusion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.07 M. Net Loss for the year was (94.9 M) with loss before overhead, payroll, taxes, and interest of (57.43 M). | |
| Fusion Pharmaceuticals currently holds about 198.42 M in cash with (81.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.57, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 87.0% of the company shares are owned by institutional investors |
Fusion Pharmaceuticals Returns Distribution Density
The distribution of Fusion Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Fusion Pharmaceuticals' future price movements. The chart of the probability distribution of Fusion Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Fusion Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Fusion Pharmaceuticals returns is essential to provide solid investment advice for Fusion Pharmaceuticals.
| Mean Return | 0.06 | Value At Risk | -5.02 | Potential Upside | 7.92 | Standard Deviation | 4.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Fusion Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Christopher Leamon of 106100 shares of Fusion PharmaceuticalsI at 8.44 subject to Rule 16b-3 [view details]
Fusion Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Fusion . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Fusion Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Fusion Pharmaceuticals? Buying financial instruments such as Fusion Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Fusion Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Currency Funds Thematic Idea Now
Currency Funds
Funds or Etfs investing in a single currency or combination of currencies from different countries in order to replicate respective foreign exchange markets. The Currency Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Currency Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Fusion Stock
If you are still planning to invest in Fusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fusion Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |